Operating Income (Loss) in USD of Neuronetics, Inc. from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Neuronetics, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2016 to Q3 2025.
  • Neuronetics, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$7,321,000.000, a 5.27% increase year-over-year.
  • Neuronetics, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$37,862,000.000, a 37.6% decline year-over-year.
  • Neuronetics, Inc. annual Operating Income (Loss) for 2024 was -$34,563,000.000, a 13.1% decline from 2023.
  • Neuronetics, Inc. annual Operating Income (Loss) for 2023 was -$30,554,000.000, a 13% increase from 2022.
  • Neuronetics, Inc. annual Operating Income (Loss) for 2022 was -$35,111,000.000, a 27.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Neuronetics, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$37,862,000 -$7,321,000 +$407,000 +5.3% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 -$38,269,000 -$8,058,000 +$449,000 +5.3% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 -$38,718,000 -$11,014,000 -$4,155,000 -60.6% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025
Q4 2024 -$34,563,000 -$11,469,000 -$7,042,000 -1.6% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025
Q3 2024 -$27,521,000 -$7,728,000 +$1,143,000 +12.9% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025
Q2 2024 -$28,664,000 -$8,507,000 -$1,158,000 -15.8% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025
Q1 2024 -$27,506,000 -$6,859,000 +$3,048,000 +30.8% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025
Q4 2023 -$30,554,000 -$4,427,000 +$3,299,000 +42.7% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025
Q3 2023 -$33,853,000 -$8,871,000 -$1,417,000 -19% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$32,436,000 -$7,349,000 +$2,447,000 +25% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 -$34,883,000 -$9,907,000 +$228,000 +2.2% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 -$35,111,000 -$7,726,000 -$817,000 -11.8% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2025
Q3 2022 -$34,294,000 -$7,454,000 -$272,000 -3.8% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 -$34,022,000 -$9,796,000 -$3,232,000 -49.2% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$30,790,000 -$10,135,000 -$3,226,000 -46.7% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$27,564,000 -$6,909,000 -$4,249,000 -1.6% 01 Oct 2021 31 Dec 2021 10-K 08 Mar 2024
Q3 2021 -$23,315,000 -$7,182,000 -$4,758,000 -2% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 -$18,557,000 -$6,564,000 +$295,000 +4.3% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022
Q1 2021 -$18,852,000 -$6,909,000 +$3,457,000 +33.3% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$22,309,000 -$2,660,000 +$4,279,000 +61.7% 01 Oct 2020 31 Dec 2020 10-K 02 Mar 2021
Q3 2020 -$26,588,000 -$2,424,000 +$3,904,000 +61.7% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 -$30,492,000 -$6,859,000 -$252,000 -3.8% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021
Q1 2020 -$30,240,000 -$10,366,000 -$3,310,000 -46.9% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q4 2019 -$26,930,000 -$6,939,000 -$1,278,000 -22.6% 01 Oct 2019 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 -$25,652,000 -$6,328,000 -$1,996,000 -46.1% 01 Jul 2019 30 Sep 2019 10-K 02 Mar 2021
Q2 2019 -$23,656,000 -$6,607,000 -$1,371,000 -26.2% 01 Apr 2019 30 Jun 2019 10-K 02 Mar 2021
Q1 2019 -$22,285,000 -$7,056,000 -$2,451,000 -53.2% 01 Jan 2019 31 Mar 2019 10-K 02 Mar 2021
Q4 2018 -$19,834,000 -$5,661,000 -$1,428,000 -33.7% 01 Oct 2018 31 Dec 2018 10-K 03 Mar 2020
Q3 2018 -$18,406,000 -$4,332,000 -$1,522,000 -54.2% 01 Jul 2018 30 Sep 2018 10-K 03 Mar 2020
Q2 2018 -$16,884,000 -$5,236,000 -$2,659,000 -1% 01 Apr 2018 30 Jun 2018 10-K 03 Mar 2020
Q1 2018 -$14,225,000 -$4,605,000 -$617,000 -15.5% 01 Jan 2018 31 Mar 2018 10-K 03 Mar 2020
Q4 2017 -$13,608,000 -$4,233,000 01 Oct 2017 31 Dec 2017 10-K 05 Mar 2019
Q3 2017 -$2,810,000 01 Jul 2017 30 Sep 2017 10-K 05 Mar 2019
Q2 2017 -$2,577,000 01 Apr 2017 30 Jun 2017 10-K 05 Mar 2019
Q1 2017 -$3,988,000 01 Jan 2017 31 Mar 2017 10-K 05 Mar 2019

Neuronetics, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$34,563,000 -$4,009,000 -13.1% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025
2023 -$30,554,000 +$4,557,000 +13% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025
2022 -$35,111,000 -$7,547,000 -27.4% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2025
2021 -$27,564,000 -$5,255,000 -23.6% 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2024
2020 -$22,309,000 +$4,621,000 +17.2% 01 Jan 2020 31 Dec 2020 10-K 07 Mar 2023
2019 -$26,930,000 -$7,096,000 -35.8% 01 Jan 2019 31 Dec 2019 10-K 08 Mar 2022
2018 -$19,834,000 -$6,226,000 -45.8% 01 Jan 2018 31 Dec 2018 10-K 02 Mar 2021
2017 -$13,608,000 -$4,271,000 -45.7% 01 Jan 2017 31 Dec 2017 10-K 03 Mar 2020
2016 -$9,337,000 01 Jan 2016 31 Dec 2016 10-K 05 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.